Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by investclubon Aug 19, 2020 8:28am
160 Views
Post# 31427091

RE:Coronavirus

RE:CoronavirusDoes this news imply that should they be successful in Covid-19 destruction it will also work on other viruses? 

Dr Coombs also stated "Based upon the above results, I believe further studies are strongly warranted. Theralases's PDCs show great promise as a potential therapeutic. Given the similar physicochemical properties of all enveloped viruses, including the new coronavirus SARS-CoV-2, I believe Theralase's PDCs represent an important new anti-viral technology platform and I am very interested in further exploring how these PDCs could be used against COVID-19." Dr. Coombs continued, "We are planning to use a Direct Electron Detector ("DED") enhancement to a powerful TALOS200 electron microscope, which allows multichannel, high-resolution imaging and precise compositional analysis to enable dynamic microscopy applications at sub-nanometer resolution. I will use this technology to look at structures of coronaviruses after they have been treated with Theralase's formulations for cellular destruction. I look forward to working with Dr. Arkady Mandel and the Theralase team in the development of this exciting technology."
<< Previous
Bullboard Posts
Next >>